Development deals

Tiny green sprout growing from soil
Biotech

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Chiesi is shelling out $115 million upfront to develop and commercialize ABO-101, a gene therapy for primary hyperoxaluria type 1.
Darren Incorvaia Oct 6, 2025 7:00am
Sign warning about erosion on a cliff

Gilead's Kite erodes $2.3B Shoreline cell therapy deal

Sep 3, 2025 3:18pm
Measuring tape on top of cash

Novo seeks obesity refresh with $550M Replicate deal

Aug 28, 2025 7:00am
Graphic of sound waves entering a persons ear

Lineage tunes up hearing loss transplant with $12M research pact

Aug 26, 2025 11:00am
Close-up of shredded document

Genentech scraps $2B cell therapy pact with Adaptive

Aug 18, 2025 2:40pm
Tightrope walker above a forest

Lilly crafts deal with UK biotech for new ALS antibodies

Jan 9, 2025 10:55am